APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Luteinizing Hormone-releasing Hormone Analogs Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17400952032 January 2026180 pages

Choose your research edition.

Industry ResearchLuteinizing Hormone-releasing Hormone Analogs Drugs Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Luteinizing Hormone-releasing Hormone Analogs Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Luteinizing Hormone-releasing Hormone Analogs Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Luteinizing Hormone-releasing Hormone Analogs Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Luteinizing Hormone-releasing Hormone Analogs Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Luteinizing Hormone-releasing Hormone Analogs Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Luteinizing Hormone-releasing Hormone Analogs Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Luteinizing Hormone-releasing Hormone Analogs Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Luteinizing Hormone-releasing Hormone Analogs Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Luteinizing Hormone-releasing Hormone Analogs Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Luteinizing Hormone-releasing Hormone Analogs Drugs include Endo, Ferring, Ipsen, LIVZON, TerSera Therapeutics, AstraZeneca, AbbVie, Sanofi and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Luteinizing Hormone-releasing Hormone Analogs Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Luteinizing Hormone-releasing Hormone Analogs Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Luteinizing Hormone-releasing Hormone Analogs Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Luteinizing Hormone-releasing Hormone Analogs Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Luteinizing Hormone-releasing Hormone Analogs Drugs Segment by Company

Endo

Ferring

Ipsen

LIVZON

TerSera Therapeutics

AstraZeneca

AbbVie

Sanofi

Takeda

Luteinizing Hormone-releasing Hormone Analogs Drugs Segment by Type

Histrelin

Taltirelin

Leuprorelin

Goserelin

Other

Luteinizing Hormone-releasing Hormone Analogs Drugs Segment by Application

Hospital

Pharmacy

Other

Luteinizing Hormone-releasing Hormone Analogs Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Luteinizing Hormone-releasing Hormone Analogs Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Luteinizing Hormone-releasing Hormone Analogs Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Luteinizing Hormone-releasing Hormone Analogs Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Luteinizing Hormone-releasing Hormone Analogs Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Luteinizing Hormone-releasing Hormone Analogs Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Luteinizing Hormone-releasing Hormone Analogs Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Luteinizing Hormone-releasing Hormone Analogs Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Luteinizing Hormone-releasing Hormone Analogs Drugs Industry Trends Table 2. Luteinizing Hormone-releasing Hormone Analogs Drugs Industry Drivers Table 3. Luteinizing Hormone-releasing Hormone Analogs Drugs Industry Opportunities and Challenges Table 4. Luteinizing Hormone-releasing Hormone Analogs Drugs Industry Restraints Table 5. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Manufacturers Table 9. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Manufacturers, Product Type & Application Table 13. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Luteinizing Hormone-releasing Hormone Analogs Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Histrelin Table 17. Major Manufacturers of Taltirelin Table 18. Major Manufacturers of Leuprorelin Table 19. Major Manufacturers of Goserelin Table 20. Major Manufacturers of Other Table 21. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Type (2021-2026) & (K Units) Table 23. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Type (2027-2032) & (K Units) Table 24. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Type (2021-2026) Table 25. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Type (2027-2032) Table 26. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Type (2021-2026) & (K Units) Table 28. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Type (2027-2032) & (K Units) Table 29. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Pharmacy Table 33. Major Manufacturers of Other Table 34. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Application (2021-2026) & (K Units) Table 36. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Application (2027-2032) & (K Units) Table 37. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Application (2021-2026) Table 38. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Application (2027-2032) Table 39. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Application (2021-2026) & (K Units) Table 41. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Application (2027-2032) & (K Units) Table 42. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Application (2021-2026) Table 43. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Application (2027-2032) Table 44. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Region (2021-2026) Table 47. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2021-2026) & (K Units) Table 51. North America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2027-2032) & (K Units) Table 52. Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2021-2026) & (K Units) Table 54. Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Region (2021-2026) Table 65. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Region (2027-2032) Table 66. Endo Company Information Table 67. Endo Business Overview Table 68. Endo Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Endo Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio Table 70. Endo Recent Development Table 71. Ferring Company Information Table 72. Ferring Business Overview Table 73. Ferring Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Ferring Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio Table 75. Ferring Recent Development Table 76. Ipsen Company Information Table 77. Ipsen Business Overview Table 78. Ipsen Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Ipsen Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio Table 80. Ipsen Recent Development Table 81. LIVZON Company Information Table 82. LIVZON Business Overview Table 83. LIVZON Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. LIVZON Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio Table 85. LIVZON Recent Development Table 86. TerSera Therapeutics Company Information Table 87. TerSera Therapeutics Business Overview Table 88. TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio Table 90. TerSera Therapeutics Recent Development Table 91. AstraZeneca Company Information Table 92. AstraZeneca Business Overview Table 93. AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio Table 95. AstraZeneca Recent Development Table 96. AbbVie Company Information Table 97. AbbVie Business Overview Table 98. AbbVie Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. AbbVie Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio Table 100. AbbVie Recent Development Table 101. Sanofi Company Information Table 102. Sanofi Business Overview Table 103. Sanofi Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Sanofi Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio Table 105. Sanofi Recent Development Table 106. Takeda Company Information Table 107. Takeda Business Overview Table 108. Takeda Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Takeda Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio Table 110. Takeda Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Luteinizing Hormone-releasing Hormone Analogs Drugs Distributors List Table 114. Luteinizing Hormone-releasing Hormone Analogs Drugs Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Luteinizing Hormone-releasing Hormone Analogs Drugs Product Image Figure 2. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (2021-2032) & (K Units) Figure 5. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Luteinizing Hormone-releasing Hormone Analogs Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Histrelin Image Figure 9. Taltirelin Image Figure 10. Leuprorelin Image Figure 11. Goserelin Image Figure 12. Other Image Figure 13. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Pharmacy Image Figure 21. Other Image Figure 22. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Application (2021-2032) Figure 25. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Country (2021-2032) Figure 42. China Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Luteinizing Hormone-releasing Hormone Analogs Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Luteinizing Hormone-releasing Hormone Analogs Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Histrelin
  • Taltirelin
  • Leuprorelin
  • Goserelin
  • Other
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Endo
  • Ferring
  • Ipsen
  • LIVZON
  • TerSera Therapeutics
  • AstraZeneca
  • AbbVie
  • Sanofi
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Dynamics
  1. 2.1 Luteinizing Hormone-releasing Hormone Analogs Drugs Industry Trends
  2. 2.2 Luteinizing Hormone-releasing Hormone Analogs Drugs Industry Drivers
  3. 2.3 Luteinizing Hormone-releasing Hormone Analogs Drugs Industry Opportunities and Challenges
  4. 2.4 Luteinizing Hormone-releasing Hormone Analogs Drugs Industry Restraints
3 Luteinizing Hormone-releasing Hormone Analogs Drugs Market by Manufacturers
  1. 3.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Luteinizing Hormone-releasing Hormone Analogs Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Luteinizing Hormone-releasing Hormone Analogs Drugs Tier 1, Tier 2, and Tier 3
4 Luteinizing Hormone-releasing Hormone Analogs Drugs Market by Type
  1. 4.1 Luteinizing Hormone-releasing Hormone Analogs Drugs Type Introduction
  2. 4.1.1 Histrelin
  3. 4.1.2 Taltirelin
  4. 4.1.3 Leuprorelin
  5. 4.1.4 Goserelin
  6. 4.1.5 Other
  7. 4.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Type
  8. 4.2.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Type
  12. 4.3.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Type (2021-2032)
5 Luteinizing Hormone-releasing Hormone Analogs Drugs Market by Application
  1. 5.1 Luteinizing Hormone-releasing Hormone Analogs Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Application
  6. 5.2.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Application
  10. 5.3.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Application (2021-2032)
6 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Region
  1. 6.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region
  1. 7.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region
  2. 7.1.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue (2021-2032)
  8. 7.2.2 North America Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Endo
  2. 8.1.1 Endo Company Information
  3. 8.1.2 Endo Business Overview
  4. 8.1.3 Endo Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Endo Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
  6. 8.1.5 Endo Recent Developments
  7. 8.2 Ferring
  8. 8.2.1 Ferring Company Information
  9. 8.2.2 Ferring Business Overview
  10. 8.2.3 Ferring Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ferring Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
  12. 8.2.5 Ferring Recent Developments
  13. 8.3 Ipsen
  14. 8.3.1 Ipsen Company Information
  15. 8.3.2 Ipsen Business Overview
  16. 8.3.3 Ipsen Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ipsen Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
  18. 8.3.5 Ipsen Recent Developments
  19. 8.4 LIVZON
  20. 8.4.1 LIVZON Company Information
  21. 8.4.2 LIVZON Business Overview
  22. 8.4.3 LIVZON Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 LIVZON Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
  24. 8.4.5 LIVZON Recent Developments
  25. 8.5 TerSera Therapeutics
  26. 8.5.1 TerSera Therapeutics Company Information
  27. 8.5.2 TerSera Therapeutics Business Overview
  28. 8.5.3 TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
  30. 8.5.5 TerSera Therapeutics Recent Developments
  31. 8.6 AstraZeneca
  32. 8.6.1 AstraZeneca Company Information
  33. 8.6.2 AstraZeneca Business Overview
  34. 8.6.3 AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
  36. 8.6.5 AstraZeneca Recent Developments
  37. 8.7 AbbVie
  38. 8.7.1 AbbVie Company Information
  39. 8.7.2 AbbVie Business Overview
  40. 8.7.3 AbbVie Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AbbVie Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
  42. 8.7.5 AbbVie Recent Developments
  43. 8.8 Sanofi
  44. 8.8.1 Sanofi Company Information
  45. 8.8.2 Sanofi Business Overview
  46. 8.8.3 Sanofi Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
  48. 8.8.5 Sanofi Recent Developments
  49. 8.9 Takeda
  50. 8.9.1 Takeda Company Information
  51. 8.9.2 Takeda Business Overview
  52. 8.9.3 Takeda Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Takeda Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
  54. 8.9.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Luteinizing Hormone-releasing Hormone Analogs Drugs Value Chain Analysis
  2. 9.1.1 Luteinizing Hormone-releasing Hormone Analogs Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Luteinizing Hormone-releasing Hormone Analogs Drugs Production Mode & Process
  6. 9.2 Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Luteinizing Hormone-releasing Hormone Analogs Drugs Distributors
  9. 9.2.3 Luteinizing Hormone-releasing Hormone Analogs Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst